Stay informed with the latest litigation news. Explore now

Dipharma competitive analysis

Latest publications and patents of Dipharma New

Explore the latest publications and patents granted to Dipharma, showcasing their recent innovations and technological advancements.

Last updated on: Sep 11, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Dipharma

Sep 29, 2021Crystalline Form Of Vortioxetine Hydrobromide As Antidepressant DrugOpposition Rejected

Explore patent oppositions filed by Dipharma against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 18, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of MeasuringBIOMARIN PHARMACEUTICALNov 9, 2022
Treatment Of Phenylketonuria With Bh4BIOMARIN PHARMACEUTICALOct 26, 2022
Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of MeasuringBIOMARIN PHARMACEUTICALJul 13, 2021
New Process For The Synthesis Of 1-(2-((2,4-Dimethylphenyl)Thio)Phenyl)PiperazineLEK PHARMACEUTICALS DDDec 5, 2019

Explore Dipharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 18, 2025
Patent NumberGrant DateTitleTotal Oppositions
Sep 29, 2021Crystalline Form Of Vortioxetine Hydrobromide As Antidepressant Drug1

Latest PTAB cases involving Dipharma New

Discover the latest PTAB cases involving Dipharma, highlighting their recent legal challenges and patent disputes.

Top competitors of Dipharma

Top competitors of Dipharma based on patent oppositions.